Literature DB >> 21255588

Tumour angiogenesis: the gap between theory and experiments.

J W Schofield1, E A Gaffney, R A Gatenby, P K Maini.   

Abstract

A common experimental technique for viewing in vivo angiogenesis utilises tumours implanted into a test animal cornea. The cornea is avascular but the tumour promotes vascularisation from the limbus and the new blood vessels can be readily observed through the transparent cornea. Many of the early mathematical models for tumour angiogenesis used this scenario as their experimental template and as such assumed that there is a large gap, of the order of 2mm, between the tumour and neighbouring vasculature at the onset of angiogenesis. In this work we consider whether the assumption that there is a significant gap between the tumour and neighbouring vasculature is unique to intra-cornea tumour implants, or whether this characterises avascular tumour growth more generally. To do this we utilise a simple scaling argument, derive a multi-compartment model for tumour growth, and consider in vivo images. This analysis demonstrates that the corneal implant experiments and the corresponding mathematical models cannot generally be applied to a clinical setting.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21255588      PMCID: PMC4010154          DOI: 10.1016/j.jtbi.2011.01.012

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  18 in total

1.  The vascularization of tumors.

Authors:  J Folkman
Journal:  Sci Am       Date:  1976-05       Impact factor: 2.142

2.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis.

Authors:  D H Ausprunk; J Folkman
Journal:  Microvasc Res       Date:  1977-07       Impact factor: 3.514

Review 3.  Mathematical modelling of angiogenesis.

Authors:  M A Chaplain
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  Tumor growth and neovascularization: an experimental model using the rabbit cornea.

Authors:  M A Gimbrone; R S Cotran; S B Leapman; J Folkman
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

Review 5.  Vascularization of tumors: a review.

Authors:  P Shubik
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

6.  Shedding of mitotic cells from the surface of multicell spheroids during growth.

Authors:  J Landry; J P Freyer; R M Sutherland
Journal:  J Cell Physiol       Date:  1981-01       Impact factor: 6.384

7.  Lattice and non-lattice models of tumour angiogenesis.

Authors:  M J Plank; B D Sleeman
Journal:  Bull Math Biol       Date:  2004-11       Impact factor: 1.758

8.  Oxygen diffusion in a spherical cell with nonlinear oxygen uptake kinetics.

Authors:  S H Lin
Journal:  J Theor Biol       Date:  1976-08-07       Impact factor: 2.691

9.  Tumor-induced neovascularization in the mouse eye.

Authors:  V R Muthukkaruppan; L Kubai; R Auerbach
Journal:  J Natl Cancer Inst       Date:  1982-09       Impact factor: 13.506

10.  Oxygen diffusivity in tumor tissue (DS-carcinosarcoma) under temperature conditions within the range of 20--40 degrees C.

Authors:  J Grote; R Süsskind; P Vaupel
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

View more
  2 in total

1.  Dynamic, heterogeneous endothelial Tie2 expression and capillary blood flow during microvascular remodeling.

Authors:  Molly R Kelly-Goss; Bo Ning; Anthony C Bruce; Daniel N Tavakol; David Yi; Song Hu; Paul A Yates; Shayn M Peirce
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

2.  Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9.

Authors:  Shimu Luo; Yanghang Ou; Tingjin Zheng; Huihui Jiang; Yibo Wu; Jiangman Zhao; Zhishan Zhang
Journal:  J Oncol       Date:  2021-12-24       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.